CGTX
HealthcareCognition Therapeutics, Inc.
$1.40
$-0.07 (-4.76%)
Jan 5, 2026
Price History (1Y)
Analysis
Cognition Therapeutics, Inc. is a biotechnology company operating in the healthcare sector with a market capitalization of $123.58M and 25 employees. As a biotech firm, it focuses on research and development. The company's financial health indicates significant losses, with net income totaling -$27,986,000 and EBITDA at -$44,802,000 over the last trailing twelve months. The operating margin, profit margin, gross margin, return on equity, and return on assets are all 0.0%, -109.7%, and -79.0%, respectively. Cognition Therapeutics has a cash balance of $39.33M and a minimal debt level of $380,000. The company's valuation is characterized by a forward P/E ratio of -4.18, an EV/EBITDA of -2.03, and a price to book ratio of 3.38. The beta value for Cognition Therapeutics stands at 1.26, indicating moderate volatility relative to the broader market.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.
Visit website →Key Statistics
- Market Cap
- $123.58M
- P/E Ratio
- N/A
- 52-Week High
- $3.83
- 52-Week Low
- $0.22
- Avg Volume
- 1.20M
- Beta
- 1.26
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 25